Overview
Obligated since award on contracts active FY2021–FY2026
Click a company to open its profile.
Insight FDA OFFICE OF ACQ GRANT SVCS (75F401) is its largest buyer. See more on the Buyers tab
About
From the company's SBA profile, updated Nov 2025
We Pharma specialize in supplying a wide range of pharmaceutical products to our customers in the most expeditious, cost effective manner possible. We are fully licensed, and have many years of experience in the pharmaceutical industry. WE Pharma is a Specialty Pharmaceutical Distributor. This means we have relationships and access to products (Brand and Generic) from manufacturers and wholesalers. We work with these manufacturers and wholesalers directly in order to find the right product at the right price to ensure our customers the best value for their money.
Agencies report with a delay; the latest year will rise
Hover over a year to see its value.
Insight Largest year: $1.32M in FY2023. See more on the Contracts tab
$6.39M since award = $5.75M in FY2021–FY2026 + $643K before FY2021
Click a state to open its page.
- Maryland$5.4M · 85%
- North Carolina$989K · 15%
Insight 85% was performed in Maryland. See more on the Contracts tab
Contracts
14 contracts with an action since FY2021
Click a tile to open its contract.
Insight 75F40121D00018 orders hold 61% of these contracts' obligations.
Click a bar to open its industry page.
Insight 67% under NAICS 424210.
Hover over a year to see its value.
Insight 54% of its prime obligations came through 75F40121D00018 orders.
Current end date of each prime contract with an action since FY2021
Hover over a month to see its value.
We Pharma, Inc. prime contracts with an action in FY2021–FY2026
Find a contract by vehicle, office or end date; sort by money to see the largest.
2 end within 12 months.
Showing 1–10 of 14 contracts
| Since award, US$ | |||||
|---|---|---|---|---|---|
| Parent contract (IDVIDV: the record type for any contract that exists to take orders: IDIQs, GWACs, GSA Schedules, BPAs and basic ordering agreements. Glossary) | ObligatedObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary | ||||
| 75F40121F19001 | 75F40121D00018 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $2,000,000 | Aug 5, 2025 | Ended |
| 75F40125F19004 | 75F40121D00018 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $1,507,060 | Aug 6, 2027 | Ends within 12 months |
| 75F40121F19005 | 75F40120D00032 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $477,944 | Jan 31, 2023 | Ended |
| 75F40123F19008 | 75F40120D00032 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $399,561 | Aug 6, 2024 | Ended |
| 75F40124F19009 | 75F40120D00032 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $357,000 | Aug 6, 2025 | Ended |
| 75F40125F19011 | 75F40120D00032 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $300,000 | Sep 16, 2026 | Ended |
| 75F40120F19002 | 75F40120D00032 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $246,754 | Sep 29, 2021 | Ended |
| 75F40118P20106 | Stand-alone | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $214,915 | Jul 15, 2020 | Ended |
| 75F40123F19003 | 75F40121D00018 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $213,614 | Sep 30, 2023 | Ended |
| 75F40123F19007 | 75F40120D00032 | FDA OFFICE OF ACQ GRANT SVCS (75F401) | $182,617 | Nov 30, 2024 | Ended |
Buyers
Food and Drug Administration: $6.39M obligated since award; $4.87M in FY2021–FY2025 actions
Click a bar to open its office page.
Insight Food and Drug Administration placed 100%.
Contracting offices that awarded We Pharma, Inc. prime contracts, FY2021–FY2026
See which offices award its contracts.
0 offices awarded only one contract.
Showing 1–1 of 1 office
| Contracts active FY2021–FY2026; obligated since award, US$ | |||||
|---|---|---|---|---|---|
| FDA OFFICE OF ACQ GRANT SVCS (75F401) | Food and Drug Administration | 14 | $6,390,019 | Jun 29, 2018 | Jul 24, 2026 |
Opportunities
Open opportunities matching We Pharma, Inc.'s registered industries
Notices in its 3 industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary): 325412, 325411, 424210
7 of the next 9 are due within 30 days.
Showing 1–9 of 9 opportunities
| Opportunity | Agency | Due |
|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America (opens in Procura)Presolicitation · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC PHARMACEUTICALS (36E797) | Oct 21, 2026 |
| Inhaled Nitric Oxide (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments | Defense Health Agency (DOD)DEFENSE HEALTH AGENCY (HT9408) | Oct 22, 2026 |
| Methylphenidate ER (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Logistics Agency (DOD)DLA TROOP SUPPORT (SPE2D2) | Oct 23, 2026 |
| Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Health Agency (DOD)DEFENSE HEALTH AGENCY (DHA) (HT0040) | Oct 26, 2026 |
| 6505--Imatinib Tablets (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC PHARMACEUTICALS (36E797) | Oct 30, 2026 |
| LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNATIONAL CMOP OFFICE (36C770) | Nov 3, 2026 |
| Epinephrine Injector (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Logistics Agency (DOD)DLA TROOP SUPPORT (SPE2D2) | Nov 16, 2026 |
| 6505--Department of Veterans Affairs Pharmaceutical Industry Day (opens in Procura)Special Notice · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC FEDERAL SUPPLY SCHEDULE (36F797) | Nov 20, 2026 |
| TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform (opens in Procura)Special Notice · NAICS 325412Free account: full notice, dates, attachments | Department of EnergyOffice 899015 | Dec 4, 2026 |
Registration and contacts
Registration
- UEI
- EWAMVJSFNK29
- CAGE code
- 7CN54
- Registration
- Active, expires Nov 4, 2026
- Entity type
- Corporate Entity (Not Tax Exempt)
- Location
- MORRISVILLE, NC, 27560
- Congressional district
- NC-02
- Established
- 2011
Registered industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary)
Registered in 3 industries; primary 424210
Contacts at We Pharma, Inc.
| Contact | Role | As of |
|---|---|---|
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Company contactSBA profileAs of Oct 4, 2026 | Oct 4, 2026 |
Correct this listing
Tell us what to correct or add on the We Pharma, Inc. page. We check every request before we change a profile.